IXC
Click for more information
5.26% 7.2¢ invex therapeutics ltd

Ann: Invex receives IND approval, page-47

  1. arkangel256
    335 Posts.
    lightbulb Created with Sketch. 147
    clock Created with Sketch.
    09/09/22
    22:33
    Post #: 63623062
    They've got to get Site Specific Approval, then after enrolled in the trial they have a 1 week screening period. My guess is that we should be hearing about the first patient dosed any week now.
    IXC Price at posting: 58.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AMI First stope ore could be pushed back to Q2 FY25 due to flood-like event: Aurelia
right-arrow Created with Sketch.
NRX Noronex joins forces with South32 to look for copper in Namibia
right-arrow Created with Sketch.
EVN Evolution shares up 3% on quarterly results for June showing rise in gold production
right-arrow Created with Sketch.
AGY Argosy signs deal to sell battery-grade Rincon lithium to Korea
right-arrow Created with Sketch.
FMG Andrew Forrest was seemingly possessed by the spirit of hydrogen – now he's cut 700 jobs and canned FFI
right-arrow Created with Sketch.
ABY Adore Beauty FY24 revenues up 7.4% YoY to $196M
right-arrow Created with Sketch.
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.2¢ 		Change
-0.004(5.26%) 		Mkt cap ! $5.411M
Open High Low Value Volume
7.3¢ 7.3¢ 7.2¢ $2.243K 30.74K

Buyers (Bids)

No. Vol. Price($)
1 38792 7.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.3¢ 4000 1
View Market Depth
Last trade - 12.37pm 22/07/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.